Corticosteroid effect on phagocytosis and NBT reduction by human polymorphonuclear neutrophils.
D000328:Adult; D000368:Aged; D001929:Brain Edema / Q000188:drug therapy; D009202:Cardiomyopathies / Q000188:drug therapy; D003864:Depression, Chemical; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000494:pharmacology*; D066298:In Vitro Techniques; D007840:Latex; D008103:Liver Cirrhosis / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy; D009504:Neutrophils / Q000378:metabolism*; D009574:Nitro Compounds / Q000097:blood / Q000378:metabolism; D010088:Oxidoreductases / Q000097:blood; D010587:Phagocytosis / Q000187:drug effects*; D011015:Pneumonia, Aspiration / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000494:pharmacology*; D013699:Temporal Arteries / Q000187:drug effects; D013778:Tetrazolium Salts / Q000097:blood / Q000378:metabolism*; D014652:Vascular Diseases / Q000188:drug therapy
D007840:Latex; D009574:Nitro Compounds; D013778:Tetrazolium Salts; D003907:Dexamethasone; D010088:Oxidoreductases; D011241:Prednisone; D006854:Hydrocortisone